Searched for
VIMPAT
Indoco Remedies gets USFDA nod to sell generic epilepsy medicineIndoco Remedies has secured approval from the US health regulator for its generic Lacosamide oral solution. This medication is used to trea...- Market movers: Adani Group stocks get 2 billion reasons to rally furtherAdani Group said Abu Dhabi’s International Holding Company PJSC (IHC) will invest $2 billion as primary capital in three portfolio companie...
- Glenmark gets tentative nod from USFDA for epilepsy drugThe company will market this product upon receiving final approval of Lacosamide Oral solution, 10 Mg/mL.
- Glenmark gets tentative US FDA nod for Lacosamide tabletsGlenmark will market this product upon receiving final approval of its Lacosamide Tablets, 50 mg, 100 mg, 150 mg and 200 mg ANDA, it added.
- Aurobindo Pharma gets tentative nod from USFDA for Lacosamide tabletsThis ANDA is at present under litigation in the United States District Court for the District of Delaware, Aurobindo Pharma said.
- Indian drugmakers switching to fresh strategies as US amends normsIndian generic drug producers are devising fresh strategies to continue benefiting from the world’s largest pharmaceutical market the Unite...
- UCB files cases against Ranbaxy, Aurobindo, Glenmark, Sun Pharma, others on patent issueUCB alongwith others has filed separate cases against as many as 15 drug makers for allegedly infringing its patented drug Vimpat.
- Top stocks in focus in Monday morning tradeMarkets are expected to turn rangebound after a sharp rally in previous session. Know the stocks which are likely to remain in focus.
- Glenmark confirms patent challenge for its generic versions of VIMPAT in the US CourtGlenmark Generics Ltd confirms that it has filed ANDAs for Lacosamide tablets and oral solution with the US drug authorities with a Paragra...
Load More
